{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:06Z","timestamp":1772165766611,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical research project of Shanghai Municipal Health Commission","award":["202340013"],"award-info":[{"award-number":["202340013"]}]},{"name":"Shanghai Key Discipline of Medical Imaging and National Clinical Key Specialty"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14307-5","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T14:30:57Z","timestamp":1747837857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of efficacy and prognostic impact of adjuvant 131I therapy at 3.7 GBq and 5.55 GBq in DTC patients with unexplained sTg elevation"],"prefix":"10.1186","volume":"25","author":[{"given":"Nan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanyong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoer","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"1","key":"14307_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid Cancer[J]. Thyroid. 2016;26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"key":"14307_CR2","doi-asserted-by":"publisher","first-page":"588024","DOI":"10.3389\/fendo.2020.588024","volume":"11","author":"ZL Qiu","year":"2020","unstructured":"Qiu ZL, Shen CT, Sun ZK, Song HJ, Xi C, Zhang GQ, et al. Long-Term outcomes and prognoses of elderly patients (\u2265\u200965-Years-Old) with distant metastases from Well-Differentiated thyroid Cancer during radioiodine therapy and Follow-Up[J]. Front Endocrinol (Lausanne). 2020;11:588024. https:\/\/doi.org\/10.3389\/fendo.2020.588024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"14307_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ecl.2018.11.005","volume":"48","author":"D Dorina Ylli","year":"2019","unstructured":"Dorina Ylli D, Van Nostrand, Leonard Wartofsky. Conventional radioiodine therapy for differentiated thyroid Cancer. Endocrinol Metab Clin North Am. 2019;48(1):181\u201397. https:\/\/doi.org\/10.1016\/j.ecl.2018.11.005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"14307_CR4","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3348\/kjr.2023.0308","volume":"24","author":"YH Roh","year":"2023","unstructured":"Roh YH, Chung SR, Baek JH, Choi YJ, Sung TY, Song DE, et al. Validation of CT-Based risk stratification system for lymph node metastasis in patients with thyroid Cancer[J]. Korean J Radiol. 2023;24(10):1028\u201337. https:\/\/doi.org\/10.3348\/kjr.2023.0308","journal-title":"Korean J Radiol"},{"key":"14307_CR5","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2021.0713","author":"EJ Ha","year":"2021","unstructured":"Ha EJ, Chung SR, Na DG, Ahn HS, Chung J, Lee JY, et al. Korean J Radiol. 2021;22(12):2094\u2013123. https:\/\/doi.org\/10.3348\/kjr.2021.0713. Korean Thyroid Imaging Reporting and Data System and Imaging-Based Management of Thyroid Nodules: Korean Society of Thyroid Radiology Consensus Statement and Recommendations[J]."},{"key":"14307_CR6","doi-asserted-by":"publisher","unstructured":"Ye F, Gong Y, Tang K, Xu Y, Zhang R, Chen S et al. Contrast-enhanced ultrasound characteristics of preoperative central cervical lymph node metastasis in papillary thyroid carcinoma[J]. Front Endocrinol (Lausanne)(2022) 13: 941905. https:\/\/doi.org\/10.3389\/fendo.2022.941905","DOI":"10.3389\/fendo.2022.941905"},{"issue":"2","key":"14307_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4274\/mirt.galenos.2022.05826","volume":"32","author":"S Sara\u00e7o\u011flu","year":"2023","unstructured":"Sara\u00e7o\u011flu S, G\u00fcven O, Babacan GB, Karya\u011far S, \u00d6z\u00fclker T, Erg\u00fcr S, et al. Comparison of radioactive iodine activities in terms of Short- and Long-term results in ablation therapy in patients with Low-risk differentiated thyroid Cancer[J]. Mol Imaging Radionucl Ther. 2023;32(2):112\u20136. https:\/\/doi.org\/10.4274\/mirt.galenos.2022.05826","journal-title":"Mol Imaging Radionucl Ther"},{"issue":"10","key":"14307_CR8","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2967\/jnumed.112.105148","volume":"53","author":"EB Silberstein","year":"2012","unstructured":"Silberstein EB, Alavi A, Balon HR, Clarke SE, Divgi C, Gelfand MJ, et al. The SNMMI practice guideline for therapy of thyroid disease with 131I. J Nucl Med. 2012;53(10):1633\u201351. https:\/\/doi.org\/10.2967\/jnumed.112.105148","journal-title":"J Nucl Med"},{"key":"14307_CR9","doi-asserted-by":"publisher","unstructured":"Signore A, Lauri C, Di Paolo A, Stati V, Santolamazza G, Capriotti G, et al. Predictive role of serum thyroglobulin after surgery and before radioactive iodine therapy in patients with thyroid Carcinoma[J]. Cancers (Basel). 2023;15(11). https:\/\/doi.org\/10.3390\/cancers15112976","DOI":"10.3390\/cancers15112976"},{"issue":"11","key":"14307_CR10","doi-asserted-by":"publisher","first-page":"e4688","DOI":"10.1210\/clinem\/dgab445","volume":"106","author":"T Tian","year":"2021","unstructured":"Tian T, Xu Y, Zhang X, Liu B. Prognostic implications of preablation stimulated Tg: A retrospective analysis of 2500 thyroid Cancer Patients[J]. J Clin Endocrinol Metab(. 2021;106(11):e4688\u201397. https:\/\/doi.org\/10.1210\/clinem\/dgab445","journal-title":"J Clin Endocrinol Metab("},{"key":"14307_CR11","doi-asserted-by":"publisher","unstructured":"Xi C, Zhang GQ, Song HJ, Shen CT, Hou LY, Qiu ZL et al. Change in Antithyroglobulin Antibody Levels is a Good Predictor of Responses to Therapy in Antithyroglobulin Antibody-Positive Pediatric Papillary Thyroid Carcinoma Patients[J]. Int J Endocrinol(2022) 2022: 7173919. https:\/\/doi.org\/10.1155\/2022\/7173919","DOI":"10.1155\/2022\/7173919"},{"issue":"18","key":"14307_CR12","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","volume":"366","author":"M Schlumberger","year":"2012","unstructured":"Schlumberger M, Catargi B, Borget I, Deandreis D, Zerdoud S, Bridji B, et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer[J]. N Engl J Med. 2012;366(18):1663\u201373. https:\/\/doi.org\/10.1056\/NEJMoa1108586","journal-title":"N Engl J Med"},{"issue":"18","key":"14307_CR13","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","volume":"366","author":"U Mallick","year":"2012","unstructured":"Mallick U, Harmer C, Yap B, Wadsley J, Clarke S, Moss L, et al. Ablation with low-dose radioiodine and Thyrotropin Alfa in thyroid cancer[J]. N Engl J Med. 2012;366(18):1674\u201385. https:\/\/doi.org\/10.1056\/NEJMoa1109589","journal-title":"N Engl J Med"},{"key":"14307_CR14","doi-asserted-by":"crossref","unstructured":"Han JM, Kim WG, Kim TY, Jeon MJ, Ryu JS, Song DE et al. Effects of low-dose and high-dose postoperative radioiodine therapy on the clinical outcome in patients with small differentiated thyroid cancer having microscopic extrathyroidal extension[J]. Thyroid(2014) 24(5): 820\u2013510.1089\/thy.2013.0362","DOI":"10.1089\/thy.2013.0362"},{"issue":"3","key":"14307_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/MNM.0b013e32834ec5d6","volume":"33","author":"M Caglar","year":"2012","unstructured":"Caglar M, Bozkurt FM, Akca CK, Vargol SE, Bayraktar M, Ugur O, et al. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer[J]. Nucl Med Commun. 2012;33(3):268\u201374. https:\/\/doi.org\/10.1097\/MNM.0b013e32834ec5d6","journal-title":"Nucl Med Commun"},{"key":"14307_CR16","doi-asserted-by":"publisher","unstructured":"Sabra MM, Grewal RK, Ghossein RA, Tuttle RM. Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases[J] thyroid(2014) 24(7): 1088\u201395. https:\/\/doi.org\/10.1089\/thy.2013.0465","DOI":"10.1089\/thy.2013.0465"},{"issue":"1","key":"14307_CR17","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1038\/s41598-019-42083-3","volume":"9","author":"SY Jeong","year":"2019","unstructured":"Jeong SY, Lee SW, Kim WW, Jung JH, Lee WK, Ahn BC, et al. Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy[J]. Sci Rep. 2019;9(1):5570. https:\/\/doi.org\/10.1038\/s41598-019-42083-3","journal-title":"Sci Rep"},{"key":"14307_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.oraloncology.2018.07.002","volume":"84","author":"SY Park","year":"2018","unstructured":"Park SY, Kim HI, Choi JY, Choe JH, Kim JH, Kim JS, et al. Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles[J]. Oral Oncol. 2018;84:41\u20135. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.07.002","journal-title":"Oral Oncol"},{"key":"14307_CR19","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.surg.2013.06.034","volume":"154","author":"S Kruijff","year":"2013","unstructured":"Kruijff S, Aniss AM, Chen P, Sidhu SB, Delbridge LW, Robinson B, et al. Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. Surgery. 2013;154:1337\u201344. https:\/\/doi.org\/10.1016\/j.surg.2013.06.034","journal-title":"Surgery"},{"issue":"1","key":"14307_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2967\/jnumed.120.243642","volume":"62","author":"L Cheng","year":"2021","unstructured":"Cheng L, Sa R, Luo Q, Fu H, Jin Y, Tang L, et al. Unexplained hyperthyroglobulinemia in differentiated thyroid Cancer patients as an indication for radioiodine adjuvant therapy: A prospective multicenter Study[J]. J Nucl Med. 2021;62(1):62\u20138. https:\/\/doi.org\/10.2967\/jnumed.120.243642","journal-title":"J Nucl Med"},{"issue":"3","key":"14307_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00259-019-04634-8","volume":"47","author":"SY Kwon","year":"2020","unstructured":"Kwon SY, Lee SW, Kong EJ, Kim K, Kim BI, Kim J, et al. Clinicopathologic risk factors of radioactive iodine therapy based on response assessment in patients with differentiated thyroid cancer: a multicenter retrospective cohort study[J]. Eur J Nucl Med Mol Imaging. 2020;47(3):561\u201371. https:\/\/doi.org\/10.1007\/s00259-019-04634-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"14307_CR22","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1245\/s10434-021-10962-7","volume":"29","author":"B Wei","year":"2022","unstructured":"Wei B, Zhao T, Shen H, Jin M, Zhou Q, Liu X, et al. Extended En bloc reoperation for recurrent or persistent parathyroid carcinoma: analysis of 31 cases in a single Institute Experience[J]. Ann Surg Oncol. 2022;29(2):1208\u201315. https:\/\/doi.org\/10.1245\/s10434-021-10962-7","journal-title":"Ann Surg Oncol"},{"issue":"1441","key":"14307_CR23","first-page":"78","volume":"129","author":"B Matti","year":"2016","unstructured":"Matti B, Cohen-Hallaleh R. Overview of the 2015 American thyroid association guidelines for managing thyroid nodules and differentiated thyroid cancer[J]. N Z Med J. 2016;129(1441):78\u201386.","journal-title":"N Z Med J"},{"key":"14307_CR24","doi-asserted-by":"publisher","unstructured":"Farias T, Kowalski LP, Dias F, Barreira CSR, Vartanian JG, Tavares MR et al. Guidelines from the Brazilian society of surgical oncology regarding indications and technical aspects of neck dissection in papillary, follicular, and medullary thyroid cancers[J].Arch endocrinol metab(2023) 67(4): e000607. https:\/\/doi.org\/10.20945\/2359-3997000000607","DOI":"10.20945\/2359-3997000000607"},{"issue":"1","key":"14307_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/RLU.0b013e318266d4d8","volume":"38","author":"A Piccardo","year":"2013","unstructured":"Piccardo A, Arecco F, Puntoni M, Foppiani L, Cabria M, Corvisieri S, et al. Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survival[J]. Clin Nucl Med. 2013;38(1):18\u201324. https:\/\/doi.org\/10.1097\/RLU.0b013e318266d4d8","journal-title":"Clin Nucl Med"},{"key":"14307_CR26","doi-asserted-by":"publisher","unstructured":"Abelleira E, Jerkovich F.Dynamic risk assessment in patients with differentiated thyroid cancer. Rev Endocr Metab Disord. 2024;25(1):79\u201393. https:\/\/doi.org\/10.1007\/s11154-023-09857-7","DOI":"10.1007\/s11154-023-09857-7"},{"issue":"3","key":"14307_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000511708","volume":"10","author":"N Mukhtar","year":"2021","unstructured":"Mukhtar N, Aljamei H, Aljomaiah A, Moria Y, Alzahrani AS. Natural course of the american\u2002thyroid\u2002association\u2002response\u2002to therapy Statuses.(Dynamic\u2002Risk Stratification) in Differentiated\u2002Thyroid\u2002Cancer. Eur Thyroid J. 2021;10(3):198\u2013207. https:\/\/doi.org\/10.1159\/000511708","journal-title":"Eur Thyroid J"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14307-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14307-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14307-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T14:31:04Z","timestamp":1747837864000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14307-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14307"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14307-5","relation":{"references":[{"id-type":"doi","id":"10.3348\/kjr.2021.0713","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5821221\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital, Shanghai 200233, China. [approval number 2023-KY-079(K)]. The study is being conducted in accordance with the Declaration of Helsinki. All participants are providing written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"912"}}